Effect of Dietary Habits on Alzheimer’s Disease Progression-Reference-Cited by-同舟云学术

Effect of Dietary Habits on Alzheimer’s Disease Progression

Published:2024 Issue:4 Volume:65 Page:217
ISSN:0513-5796
Container-title:Yonsei Medical Journal
language:en
Short-container-title:Yonsei Med J

Author:

Ahn So Hyun¹^ORCID,Jeong Jee Hyang²^ORCID,Park Kyung Won³^ORCID,Kim Eun-Joo⁴^ORCID,Yoon Soo Jin⁵^ORCID,Yoon Bora⁶^ORCID,Jang Jae-Won⁷^ORCID,Minn Yangki¹^ORCID,Choi Seong Hye⁸^ORCID

Affiliation:

1. Department of Neurology, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.

2. Department of Neurology, Ewha Womans University College of Medicine, Seoul, Korea.

3. Department of Neurology, Dong-A Medical Center, Dong-A University College of Medicine, Busan, Korea.

4. Department of Neurology, Pusan National University Hospital, Pusan National University School of Medicine and Medical Research Institute, Busan, Korea.

5. Department of Neurology, Eulji University Hospital, Eulji University School of Medicine, Daejeon, Korea.

6. Department of Neurology, Konyang University College of Medicine, Daejeon, Korea.

7. Department of Neurology, Kangwon National University School of Medicine, Chuncheon, Korea.

8. Department of Neurology, Inha University College of Medicine, Incheon, Korea.

Funder

Inha University

Publisher

XMLink

Link

https://eymj.org/pdf/10.3349/ymj.2023.0119

Reference40 articles.

1. Dementia prevention, intervention, and care

2. Biogen CEO says $56,000 annually for Alzheimer’s drug is ‘fair,’ promises not to hike price for at least 4 years [Internet]. accessed on 2023 January 10. Available at: https://www.cnbc.com/2021/06/07/biogen-ceo-says-56000-annually-for-alzheimers-drug-is-fair-promises-not-to-hike-price-for-at-least-4-years.html

3. Cost‐effectiveness of aducanumab to prevent Alzheimer's disease progression at current list price

4. A Clinical Trial of the Effects of Dietary Patterns on Blood Pressure

5. Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease